Dutasteride in Androgenetic Alopecia: An Update

Publisher： Bentham Science Publishers

E-ISSN： 2212-3938|12|1|31-35

ISSN： 1574-8847

Source： Current Clinical Pharmacology, Vol.12, Iss.1, 2017-06, pp. : 31-35

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New investigational drugs for androgenetic alopecia

By Valente Duarte de Sousa Isabel Cristina   Tosti Antonella  

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 5, 2013-05 ,pp. : 573-589

Informa Healthcare

Access to resources Recommend Favorite

Evidence-based therapy of androgenetic alopecia

By Wolff Hans  

PHARMAKON, Vol. 2, Iss. 3, 2014-05 ,pp. : 183-186

Govi-Verlag

Access to resources Recommend Favorite

Testosterone enantate: Androgenetic alopecia: case report

By  

Reactions Weekly, Vol. 1, Iss. 1403, 2012-01 ,pp. : 32-33

Adis International

Access to resources Recommend Favorite

Treatments for Androgenetic Alopecia and Alopecia Areata: Current Options and Future Prospects

By Meidan V.M.   Touitou E.  

Drugs, Vol. 61, Iss. 1, 2001-01 ,pp. : 53-69

Adis International

Access to resources Recommend Favorite

Finasteride, a Type 2 5-reductase inhibitor, in the treatment of men with androgenetic alopecia

By Kaufman K.D.   Dawber R.P.  

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 4, 1999-04 ,pp. : 403-415

Informa Healthcare

Access to resources Recommend Favorite